Pharmaleaders attempt is to recognize and celebrate science and innovation in the pharmaceutical, biotechnology, lifescience & healthcare industry. At the celebration day of the Awards, Companies, Academics, Partners, Government and Delegates get a glimpse of Pharmaleaders’s ongoing research and a walk through of the Network 7 Media Group ’s most recent innovations in the complex field of understanding & analyzing genes of the healthcare industry as Pharmaleaders feel that “no one understands the returning the smiles to the achievers they deserve most”
“Regarding the 2014, the 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014, we have been honoring outstanding scientific contributions for more than a decade and are privileged to recognize the work of accomplished leaders “As a true friend, philosopher & guide, we are deeply committed to creating a more sustainable future through scientific research and we will continue to support visionary pharma leaders as they strive to advance our understanding in all fields of the pharmaceutical & healthcare industry. “The Pharmaceutical Leadership & Pharmaleaders Business Leadership Awards” was first bestowed in India in 19991 In order to reflect the increasingly global nature of the awards, it was then revaluated & reshaped in more credible formats in the year 2008 & since than these awards serve as a benchmark of innovation.
May 2015 Edition of BEACON, A Monthly Newsletter by SIMCON.
Inside this issue:
About Us
Our Team
INDUSTRY ANALYSIS : Pharmaceutical Industry
COMPANY ANALYSIS : Sun Pharma
BRAND ANALYSIS : Kellogg's
Concept of the month
It is the financial statement analysis of the two pharmaceutical companies in Bangladesh.
Sqaure Pharma. SPL
BEXIMCO Pharma BPL
for Ms. Mahtab Faruqui's FIN301 Class at BRAC University
May 2015 Edition of BEACON, A Monthly Newsletter by SIMCON.
Inside this issue:
About Us
Our Team
INDUSTRY ANALYSIS : Pharmaceutical Industry
COMPANY ANALYSIS : Sun Pharma
BRAND ANALYSIS : Kellogg's
Concept of the month
It is the financial statement analysis of the two pharmaceutical companies in Bangladesh.
Sqaure Pharma. SPL
BEXIMCO Pharma BPL
for Ms. Mahtab Faruqui's FIN301 Class at BRAC University
WealthZap Research Services-Cadila Heathcare Ltd MultiBagger Recommendation f...Saurabh
CHL is our typical Multibagger stock, but a Stock which is a Good Investment under current Market conditions. It has a presence in a space which offers enormous potential and is also trading at reasonable valuations which will deliver superior returns in the long run.
Core Investment Thesis :
The company is in healthcare space and is one of the fastest growing pharma companies among top-10 domestic peers. It currently ranks as the 4th largest pharmaceutical company in India with a market share of ~4.2%, based on domestic sales of formulations.
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
Indian Affairs, Asia’s biggest news title has been relentlessly pursuing the need for a change in approach as the old order is beginning to crumple & political compulsions have dominated economic growth. We have no options, but to leave with its reality. Over the last few years, Indian Affairs & Breakfastnews has been at the centre of debating the uneasy questions & posing uncomfortable questions as Network 7 Media Group refuses to compromise on journalism ethics & principles of propriety. Indian Affairs has exposed the real villions of Indian polity who try to subvert the system for their personal gains. Our attempt to bring truth & credibility has given discomfort to many in the corridors of power & bunch of jokers at the helm of administration, but our struggle for bringing the truth remain the principle mantra, how much opposition we face. Indian Affairs is restless & in an attempt to cleanse the system through journalism has also discovered that India today is not the same as it was a decade a back. International Community today is looking at India with a much bigger anticipation as the past few years have brought disrepute following scams after scams paralyzing the policy reforms. Domestic turbulence & apathy towards the system have brought people to the streets as they protest that their rights are snatched away. India today is a new india.
Pharmaleaders attempt is to recognize and celebrate science and innovation in the pharmaceutical, biotechnology, lifescience & healthcare industry. At the celebration day of the Awards, Companies, Academics, Partners, Government and Delegates get a glimpse of Pharmaleaders’s ongoing research and a walk through of the Network 7 Media Group ’s most recent innovations in the complex field of understanding & analyzing genes of the healthcare industry as Pharmaleaders feel that “no one understands the returning the smiles to the achievers they deserve most”
“Regarding the 2014, the 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014, we have been honoring outstanding scientific contributions for more than a decade and are privileged to recognize the work of accomplished leaders “As a true friend, philosopher & guide, we are deeply committed to creating a more sustainable future through scientific research and we will continue to support visionary pharma leaders as they strive to advance our understanding in all fields of the pharmaceutical & healthcare industry. “The Pharmaceutical Leadership & Pharmaleaders Business Leadership Awards” was first bestowed in India in 19991 In order to reflect the increasingly global nature of the awards, it was then revaluated & reshaped in more credible formats in the year 2008 & since than these awards serve as a benchmark of innovation.
India Leadership Conclave & Indian Affairs Business Leadership Awards organized by Network7 Media Group’s Indian Affairs is Asia’s most eagerly awaited leadership event where the platform has established a credible platform of serious discussion where Brand India’s most illustrious Leaders & icons assemble to discuss the roadmap for India’s growth trajectory. The last three Annual Affairs at the India Leadership Conclave Platform, we have witnessed some of the biggest think-tanks of the contemporary leaders in society from social to political & from business to cultural has addressed, deliberated & opened up the new mantras of developments. While more than 300 Leaders of Indian mainstream polity have spoken, the platform has recognized & honoured more than top 500 Leaders & Enterprises over the last four annual editions. Indian Affairs Business Leadership Awards 2013 are set of prestigious awards developed by the eminent Juries & bestowed to the deserving Leaders & Enterprises after a through screening of their landmark achievements for their significant accomplishments in their own fields who have performed under tough conditions imbibing innovation in their business approach.
WealthZap Research Services-Cadila Heathcare Ltd MultiBagger Recommendation f...Saurabh
CHL is our typical Multibagger stock, but a Stock which is a Good Investment under current Market conditions. It has a presence in a space which offers enormous potential and is also trading at reasonable valuations which will deliver superior returns in the long run.
Core Investment Thesis :
The company is in healthcare space and is one of the fastest growing pharma companies among top-10 domestic peers. It currently ranks as the 4th largest pharmaceutical company in India with a market share of ~4.2%, based on domestic sales of formulations.
This PPT contains complete analysis of Pharmaceutical Industry including worldwide and nationwide picture, leading organizations, SWOT analysis, Government policies and regulations, challenges and solutions.
Indian Affairs, Asia’s biggest news title has been relentlessly pursuing the need for a change in approach as the old order is beginning to crumple & political compulsions have dominated economic growth. We have no options, but to leave with its reality. Over the last few years, Indian Affairs & Breakfastnews has been at the centre of debating the uneasy questions & posing uncomfortable questions as Network 7 Media Group refuses to compromise on journalism ethics & principles of propriety. Indian Affairs has exposed the real villions of Indian polity who try to subvert the system for their personal gains. Our attempt to bring truth & credibility has given discomfort to many in the corridors of power & bunch of jokers at the helm of administration, but our struggle for bringing the truth remain the principle mantra, how much opposition we face. Indian Affairs is restless & in an attempt to cleanse the system through journalism has also discovered that India today is not the same as it was a decade a back. International Community today is looking at India with a much bigger anticipation as the past few years have brought disrepute following scams after scams paralyzing the policy reforms. Domestic turbulence & apathy towards the system have brought people to the streets as they protest that their rights are snatched away. India today is a new india.
Pharmaleaders attempt is to recognize and celebrate science and innovation in the pharmaceutical, biotechnology, lifescience & healthcare industry. At the celebration day of the Awards, Companies, Academics, Partners, Government and Delegates get a glimpse of Pharmaleaders’s ongoing research and a walk through of the Network 7 Media Group ’s most recent innovations in the complex field of understanding & analyzing genes of the healthcare industry as Pharmaleaders feel that “no one understands the returning the smiles to the achievers they deserve most”
“Regarding the 2014, the 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014, we have been honoring outstanding scientific contributions for more than a decade and are privileged to recognize the work of accomplished leaders “As a true friend, philosopher & guide, we are deeply committed to creating a more sustainable future through scientific research and we will continue to support visionary pharma leaders as they strive to advance our understanding in all fields of the pharmaceutical & healthcare industry. “The Pharmaceutical Leadership & Pharmaleaders Business Leadership Awards” was first bestowed in India in 19991 In order to reflect the increasingly global nature of the awards, it was then revaluated & reshaped in more credible formats in the year 2008 & since than these awards serve as a benchmark of innovation.
India Leadership Conclave & Indian Affairs Business Leadership Awards organized by Network7 Media Group’s Indian Affairs is Asia’s most eagerly awaited leadership event where the platform has established a credible platform of serious discussion where Brand India’s most illustrious Leaders & icons assemble to discuss the roadmap for India’s growth trajectory. The last three Annual Affairs at the India Leadership Conclave Platform, we have witnessed some of the biggest think-tanks of the contemporary leaders in society from social to political & from business to cultural has addressed, deliberated & opened up the new mantras of developments. While more than 300 Leaders of Indian mainstream polity have spoken, the platform has recognized & honoured more than top 500 Leaders & Enterprises over the last four annual editions. Indian Affairs Business Leadership Awards 2013 are set of prestigious awards developed by the eminent Juries & bestowed to the deserving Leaders & Enterprises after a through screening of their landmark achievements for their significant accomplishments in their own fields who have performed under tough conditions imbibing innovation in their business approach.
Pharmaleaders attempt is to recognize and celebrate science and innovation in the pharmaceutical, biotechnology, lifescience & healthcare industry. At the celebration day of the Awards, Companies, Academics, Partners, Government and Delegates get a glimpse of Pharmaleaders’s ongoing research and a walk through of the Network 7 Media Group ’s most recent innovations in the complex field of understanding & analyzing genes of the healthcare industry as Pharmaleaders feel that “no one understands the returning the smiles to the achievers they deserve most”
“Regarding the 2014, the 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014, we have been honoring outstanding scientific contributions for more than a decade and are privileged to recognize the work of accomplished leaders “As a true friend, philosopher & guide, we are deeply committed to creating a more sustainable future through scientific research and we will continue to support visionary pharma leaders as they strive to advance our understanding in all fields of the pharmaceutical & healthcare industry. “The Pharmaceutical Leadership & Pharmaleaders Business Leadership Awards” was first bestowed in India in 19991 In order to reflect the increasingly global nature of the awards, it was then revaluated & reshaped in more credible formats in the year 2008 & since than these awards serve as a benchmark of innovation.
India Leadership Conclave & Indian Affairs Business Leadership Awards organized by Network7 Media Group’s Indian Affairs is Asia’s most eagerly awaited leadership event where the platform has established a credible platform of serious discussion where Brand India’s most illustrious Leaders & icons assemble to discuss the roadmap for India’s growth trajectory. The last three Annual Affairs at the India Leadership Conclave Platform, we have witnessed some of the biggest think-tanks of the contemporary leaders in society from social to political & from business to cultural has addressed, deliberated & opened up the new mantras of developments. While more than 300 Leaders of Indian mainstream polity have spoken, the platform has recognized & honoured more than top 500 Leaders & Enterprises over the last four annual editions. Indian Affairs Business Leadership Awards 2013 are set of prestigious awards developed by the eminent Juries & bestowed to the deserving Leaders & Enterprises after a through screening of their landmark achievements for their significant accomplishments in their own fields who have performed under tough conditions imbibing innovation in their business approach.
Indian Affairs, India Leadership Conclave 2015, Indian Affairs Business Leadership Awards 2015, Satya Brahma, Network 7 Media Group, ILC power Brands,6th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2015, Indian Affairs Indian of the year 2015
3rd annual pharmaceutical leadership summit 2014 white paper Indian Affairs
It is widely believed that the consolidations in the Indian pharma sector is likely to continue, particularly among generic drug players and will drive shareholder value going forward.India-based pharmaceutical companies have majorly been absent from much of the recent M&A activities, partly because of their healthy growth outlooks. The global pharmaceutical industry will continue to undergo a pace of rapid consolidation to drive shareholder value; particularly in the case of companies seeking new growth platforms, against the backdrop of patent expirations.With many drugs going off patent in the US, Indian pharma companies would continue to experience strong growth in American market, indian pharma companies would continue to experience strong growth in the US over the medium-term. This would be driven by the sizable generic opportunity (drugs with brand value of $25-30 billion are expected to face generic competition) over the next 2-3 years. As one of the recently industrialized nations, India has a fast-growing economy as well as an ever-expanding, ever-urbanized population, however its healthcare system still has a lot of potential for development. To Western readers, analyzing a healthcare system in the East seems daunting. It takes some of us decades to master an understanding of the healthcare system of our origin country. Nevertheless, there are several methods to approaching another country’s system. These include the exposition of some invariant principles that apply across various contexts, the application of existing frameworks for healthcare system analysis, appraisal of the major transitions underway in the country, and an analysis of the country’s public health issues. India faces challenges in pursuing each of these goals. With regards to cost, at least 70% of all healthcare is frequently financed out-of-pocket by the population. There is little health insurance or other forms of risk pooling, little regulation and accountability of providers, and a predominance of fee-for-service payment, all of which are associated with high costs. There is also questionable efficiency of much of the state healthcare system, and a great distrust of the public sector. Against the backdrop of the above challenges, Pharmaleaders has lined up top industry experts, Pharma Academia, Ministry Officials, Government Representative, Policy Makers & Medical Professionals under one platform both in india & abroad to debate & deliberate the complex issues of the industry & give a meaningful discussion on the Brand India & Make In India concept. More than 300 professionals will be participating the mega event where professionals from Middle East, Africa, Europe, Lation America will also be attending.The historic 7th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2014 to be held in a uniquely positioned full day program encompassing two themes “Make In India – Healthcare Reforms , Insurance,Innovations,Investments & Infrastructur
Pharmaleaders attempt is to recognize and celebrate science and innovation in the pharmaceutical, biotechnology, lifescience & healthcare industry. At the celebration day of the Awards, Companies, Academics, Partners, Government and Delegates get a glimpse of Pharmaleaders’s ongoing research and a walk through of the Network 7 Media Group ’s most recent innovations in the complex field of understanding & analyzing genes of the healthcare industry as Pharmaleaders feel that “no one understands the returning the smiles to the achievers they deserve most”
“Regarding the 2014, the 7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014, we have been honoring outstanding scientific contributions for more than a decade and are privileged to recognize the work of accomplished leaders “As a true friend, philosopher & guide, we are deeply committed to creating a more sustainable future through scientific research and we will continue to support visionary pharma leaders as they strive to advance our understanding in all fields of the pharmaceutical & healthcare industry. “The Pharmaceutical Leadership & Pharmaleaders Business Leadership Awards” was first bestowed in India in 19991 In order to reflect the increasingly global nature of the awards, it was then revaluated & reshaped in more credible formats in the year 2008 & since than these awards serve as a benchmark of innovation.
Project on Production and Packaging in Pharmaceutical Industry Emcure By Nikh...Nikhil Dhawan
This is the Complete Project that I`ve Completed on 7/08/2014 and It is Now Brand New Project Report Suitable for Students doing MBA, PGDBM and Having Topics like Marketing or HR. No Ads, No Price, No Money!
You Can Contact Me for More Free Projects! Just Download the Project and Enjoy! Cheers!!
Best of Luck
Nikhil Dhawan
9018580277, 9622334428
nikdhawan@outlook.com.
contactnikhildhawan@gmail.com.
contact_nikhildhawan@gmail.com
How Can Pharma Sales Leaders Create A Winning Sales Organisation?Anup Soans
Inside this Issue
1. Interview with Salil Kallianpur – with Anup Soans, Editor – MedicinMan
“There is much work to be done and a unified pharma industry can prove to be a valuable ally to the government.”
2. Patient-centricity: How Pharma Can Move from Intention to Action by Hanno Wolfram
Patient-centricity begins with moving from talking about the patient to talking to the patient
3. The Corporate Halo Effect by Vivek Hattangadi
How a great corporate brand elevates a company’s products in the minds of doctors and patients
4. For a Positive Attitude, Clean Your Mind’s Windows by Asheesh Kumar Patel
A bad attitude is a learned behavior and can be unlearned when we discover it’s source
5. The Three Transformations for Leadership by Srinivasan Athmanathan
Three key professional traits that every successful leader must possess
6. Book Review: Feather in a C.A.P. by Kamalesh Subramanian
A corporate saga with valuable lessons for professionals of all backgrounds
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGESganpat420
Abstract
Introduction
Global pharmaceutical industry
Indian pharmaceutical industry
Indian Pharmaceutical Market
Opportunities
Challenges
Conclusion
References
The Indian markets and financial institutions stand out as sound, stable and better
regulated in contrast to developed economies. As a result, India can continue to be an
attractive market in view of its strong and stable fundamentals and the resilience which
Indian economy has displayed so far
India Leadership Conclave Annual Affairs Power Brand Awards 2021Indian Affairs
Rated by Experts & widely acclaimed by thought leaders, India Leadership Conclave Annual Affair is just not a leadership forum, it symbolizes the hopes & aspirations of the billion people
India Leadership Conclave 2021 White Paper Focusses on ReformsIndian Affairs
India Leadership Conclave 2021 White Paper Focusses on Reforms.Rated by Experts & widely acclaimed by thought leaders, India Leadership Conclave Annual Affair is just not a leadership forum, it symbolizes the hopes & aspirations of the billion people
Rated by Experts & widely acclaimed by thought leaders, India Leadership Conclave Annual Affair is just not a leadership forum, it symbolizes the hopes & aspirations of the billion people
K. Prakash Shetty The founder Chairman of MRG Group Featured at India Leaders...Indian Affairs
K. Prakash Shetty The founder Chairman of MRG Group Featured at India Leadership Conclave 2021.The founder Chairman of MRG Group and Kannada Rajyotsava Awardee , Mr K. Prakash Shetty is a passionate and committed hospitality magnate with over two and half decades of experience in the realms of hospitality and real estate. His passion for fine dining began with the launch of Banjara in 1993, from whence there has been no looking back. Mr Shetty is also committed to societal needs and a strong leaning to help the poor and underprivileged.
Over the years, Mr Shetty has won many accolades and recognition from both the state and national government. He was honoured by the Bruhuth Bangalore Hotel Associations, at their Amruth Mahotsav celebrations, for his contribution to the society and his achievements in the Hotel Industry. Recently, he was awarded the ‘Kannada Rajyotsava Award’, the second highest state civilian award in 2019, for outstanding acievements in the hospitality sector and contributions to the society by the Honourable Government of Karnataka . He has also been conferred with the Best Intellectual Award in Corporate Leadership by the Global Achievers Foundation, and the Bharath Gaurav Ratan Award by the Indian Organization for Commerce and Industry for his outstanding services, achievements, and contributions to the Hospitality Industry.
Philanthropist-Entrepreneur K Prakash Shetty Honoured with prestigious Indian...Indian Affairs
Korangrapady Prakash Shetty, Chairman of MRG Group bagged the top recognition for innovations, visionary entrepreneurship & change-agent in social philanthropy at the India Leadership Conclave 2020, nation's most respected leadership brand
MRG Group Chairman K Prakash Shetty bagged the prestigious Indian Affairs Visionary Leader of the Year 2020 at the 11th Annual India Leadership Conclave & Indian Affairs Power Brand Awards held recently on 26th of December 2020 under the theme Rebuilding India : Opportunities in the pandemic. The event witnessed top global voices deliberating on crucial issues following the impact of Cocid-19 pandemic. Korangrapady Prakash Shetty of Marg Group was in nation-wide voting process of six finalists conducted by Network 7 Research. The public mandate & Jury selected K. Prakash Shetty for the coveted title. India Leadership Conclave & Indian Affairs Business Leadership Awards organized by Network7 Media Group's Indian Affairs is Asia's most eagerly awaited leadership event where the platform has established a credible platform of serious discussion where Brand India's most illustrious Leaders & icons assemble to discuss the roadmap for India's growth trajectory.
I believe that we have a responsibilities to look beyond the headlines while assessing the state of healthcare affairs in india. There is no denying the fact that Healthcare Innovations is crucial where the innovators are engaged in disrupting the field with research breakthrough & path breaking ideas. Pharma Leaders Panel debates engage these innovators. Innovation is embarking on an endless journey. Innovation involves looking inside
I believe that we have a responsibilities to look beyond the headlines while assessing the state of healthcare affairs in india. There is no denying the fact that Healthcare Innovations is crucial where the innovators are engaged in disrupting the field with research breakthrough & path breaking ideas. Pharma Leaders Panel debates engage these innovators. Innovation is embarking on an endless journey. Innovation involves looking inside
We believe that we have a responsibilities to look beyond the headlines while assessing the state of healthcare affairs in india. There is no denying the fact that Healthcare Innovations is crucial where the innovators are engaged in disrupting the field with research breakthrough & path breaking ideas. Pharma Leaders Panel debates engage these innovators. Innovation is embarking on an endless journey. Innovation involves looking inside
Innovation in medical device and diagnostic industry at India Leadership Conc...Indian Affairs
Conceptualized& instituted in the year by India’s most respected journalist Satya Brahma, India Leadership Conclave Awards are are meant to highlight & celebrate those individuals & companies who’ve ascended to the top of their business against all odds. Currently celebrating its 9th successful annual editions, iconic figures such as Ratata Tata, MukeshAmbani, Naresh Goyal, Narayan Murthy, Shiv Nadar,SudhaMurthy,Priyanka Chopra, Manish Malhotra, Neeta Lulla, Late Yash Chopra, Govinda, Rani Mukerjee, Sushimita Sen, Karishma Kapoor are some of its proud recipients. Being India’s most iconic leadership awards having a tremendous impact on the credibility of the Group, India Leadership Conclave jury takes every steps to ensure fair, credible & independent selection process,.The nomination categories, eligibility criteria, selection process & evaluation criteria constitute the core areas of research. Public voting constitutes its biggest parameters. Physical interviews by Network 7 Media Group Journalists on ground on each nominee are conducted followed by Jury’s strong analytical verdict. The set of awards developed by the Board Members of the Network 7 Media Group is to propel the talent engine & encourage, motivate the innovative entrepreneurs. These leadership awards are aimed at empowering the leaders who think differently.This recognition voted by the people of india& subsequent by Jury Board reflect the Winner’s remarkable achievement & accomplishments as a leader of substance driven by passion, initiative & commitment to deliver excellence. India Leadership Conclave Awards are special as we don’t follow any traditional guidelines, defy conventions & crown winners based on innovations, merit & competence. Our decision is based on number of factors which are transparent, robust & driven by extensive research.
Dr Shuba Dharmana at India Leadership Conclave Indian Affairs
Conceptualized& instituted in the year by India’s most respected journalist Satya Brahma, India Leadership Conclave Awards are are meant to highlight & celebrate those individuals & companies who’ve ascended to the top of their business against all odds. Currently celebrating its 9th successful annual editions, iconic figures such as Ratata Tata, MukeshAmbani, Naresh Goyal, Narayan Murthy, Shiv Nadar,SudhaMurthy,Priyanka Chopra, Manish Malhotra, Neeta Lulla, Late Yash Chopra, Govinda, Rani Mukerjee, Sushimita Sen, Karishma Kapoor are some of its proud recipients. Being India’s most iconic leadership awards having a tremendous impact on the credibility of the Group, India Leadership Conclave jury takes every steps to ensure fair, credible & independent selection process,.The nomination categories, eligibility criteria, selection process & evaluation criteria constitute the core areas of research. Public voting constitutes its biggest parameters. Physical interviews by Network 7 Media Group Journalists on ground on each nominee are conducted followed by Jury’s strong analytical verdict. The set of awards developed by the Board Members of the Network 7 Media Group is to propel the talent engine & encourage, motivate the innovative entrepreneurs. These leadership awards are aimed at empowering the leaders who think differently.This recognition voted by the people of india& subsequent by Jury Board reflect the Winner’s remarkable achievement & accomplishments as a leader of substance driven by passion, initiative & commitment to deliver excellence. India Leadership Conclave Awards are special as we don’t follow any traditional guidelines, defy conventions & crown winners based on innovations, merit & competence. Our decision is based on number of factors which are transparent, robust & driven by extensive research.
Dr. Sudhakar Shinde at India Leadership Conclave 2019Indian Affairs
National Health Protection Scheme - Challenges of ensuring Quality Healthcare at Affordable Costs.
Dr. Sudhakar Shinde, CEO, Mahatma Jyotiba Phule Jan Arogya Yojana (MPJAY)
Making india $5 trillion economy REVA University Feature at India Leadership ...Indian Affairs
Making india $5 trillion economy REVA University Feature at India Leadership Conclave 2019. More than 300 Business Tycoons, Social Entrepreneurs, Industry Leaders, Educationists, Policy Makers were in full attendance to witness the much awaited 10th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2019, also known as ILC Power Brand Awards. The historic & iconic annual conclave currently in its 10th annual edition debated on the theme “Opportunities - Can India Seize India $5 trillion economy by 2025”. Leading voices & noted leaders of the country gathered at the commercial capital of india in mumbai on friday,23rd August 2019. The conclave highlighted the burning topics of india with a specific emphasis on Modi 2.0.
Sonal Holland at indian leadership conclave 2019Indian Affairs
Understanding the Business of Wine - What will drive India's wine & food tourism to the next level?
Ms. Sonal Holland, Founder,Sonal Holland Wine Academy & Soho Wine Club at 10th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards
India Leadership Conclave 2019 - "Opportunities" - The 5 Trillion Dollar Miss...Indian Affairs
India's $5 trillion-economy plans looks good on paper but it needs to address gaps. India Leadership Conclave is of the opinion that India needs foreign direct investment (FDI) urgently, and lots of it. Since FDI, unlike portfolio investment, is long-term patient capital, entrepreneurs and bankers like to examine proposals very carefully.
India’s record on the dispute resolution front has also proved to be extremely worrying. That is why most investors prefer to insert a clause allowing for international arbitration from a seat outside of India.
India Leadership Conclave 2019 - "Opportunities" - The 5 Trillion Dollar Miss...Indian Affairs
India's $5 trillion-economy plans looks good on paper but it needs to address gaps. India Leadership Conclave is of the opinion that India needs foreign direct investment (FDI) urgently, and lots of it. Since FDI, unlike portfolio investment, is long-term patient capital, entrepreneurs and bankers like to examine proposals very carefully.
India’s record on the dispute resolution front has also proved to be extremely worrying. That is why most investors prefer to insert a clause allowing for international arbitration from a seat outside of India.
India Leadership Conclave 2019 - "Opportunities" - The 5 Trillion Dollar Miss...Indian Affairs
India's $5 trillion-economy plans looks good on paper but it needs to address gaps. India Leadership Conclave is of the opinion that India needs foreign direct investment (FDI) urgently, and lots of it. Since FDI, unlike portfolio investment, is long-term patient capital, entrepreneurs and bankers like to examine proposals very carefully.
India’s record on the dispute resolution front has also proved to be extremely worrying. That is why most investors prefer to insert a clause allowing for international arbitration from a seat outside of India.
India Leadership Conclave 2019 - "Opportunities" - The 5 Trillion Dollar Miss...Indian Affairs
There is no doubt that Narendra Modi’s ruling Bharatiya Janata Party is an election-winning machine. But Indian Affairs feels that its ideology is sharply at odds with economic or social common sense.
Results for India's general election released on 23 May saw a landslide victory for the Bharatiya Janata Party (BJP), which increased its huge parliamentary majority. Narendra Modi and his ruling BJP have swept back to power. The party won 303 seats in the Lok Sabha, the lower house of India's parliament, bettering the 282 seats they won in 2014 - a performance that not many thought was possible. BJP's historic win decimated the Opposition.
India Leadership Conclave currently in its 10th Annual Year is hosting the iconic & historic 10th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2019 with a powerful & aptly theme of OPPORTUNITIES where we intend to do a post mortem of how the first term of the Modi Government has fared & what is in store for Modi 2.0.
Indian Affairs India Leadership Conclave 2019Indian Affairs
The timing of hosting this historic & iconic conclave titled "Opportunities" - The 5 Trillion Dollar Mission : Challenges & Opportunities assumes tremendous significance in view of the historic mandate received by the Prime Minister Narendra Modi virtually decimating the opposition & riding on to take Brand india to the global map
There are two important & significant landmarks post the second term of the Modi Government. Chandrayaan-2 launch from the Satish Dhawan Space Centre at Sriharikota from its most powerful rocket with a plan to land the rover on September 7 in the unexplored lunar south pole. Carrying a "billion dreams" in a giant leap for the country's ambitious low-cost space programme, the most complex and prestigious mission ever undertaken by the Indian Space Research Organisation(ISRO) making India the fourth country after Russia, the US and China.
India Leadership Conclave is india’s most definitive destination of leadership gatherings of the influential leaders of the country & abroad with a focus to continuously innovate & debate ideas that are complex & important. Over the last nine editions, India Leadership conclave has emerged not only as a leadership brand but also defied the age old practices of rules & traditions that are irrelevant, Indian Affairs, the flagship media brand of Network 7 Media Group is hosting the high profile 10th Annual India Leadership Conclave & Indian Affairs Business Leadership Awards 2019, also known as ILC Power Brand in Mumbai on Friday,23rd August 2019 at the Grand Jade Ball Room, Hotel Sahara Star Mumbai, India in partnership with top govt agencies & apex trade bodies under the theme "Opportunities". More than 350 influential leaders of the country from politics to business, health to social & others has blocked the date to witness the ultimate. The conclave starts over a breakfast & is debating on a powerful theme “Opportunities” to be addressed by the business tycoons, rebel leaders, authors, social & healthcare reformers in recent times. The day long conclave will be culminated on the much awaited annual award ceremony in a glittering award night where who's who's of india will be present.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
1. Developed by
6th
Annual
Pharmaceutical
Leadership Summit
2013TM
Pharmaceutical Leadership Summit &
Business Leadership Awards 2013
6th
Annual
Pharmaceutical
Leadership Summit
2013TM
6th Annual
GET READY TO ATTEND ASIA’S
BIGGEST LEADERSHIP
EXPERIENCE IN HEALTH CARE
6th ANNUAL PHARMACEUTICAL LEADERSHIP
SUMMIT & BUSINESS LEADERSHIP AWARDS 2013
INCREDIBLE PHARMALEADERS 2013
BILLION DREAMS-PUSHING INDIA'S GROWTH AGENDA
Friday,27st December 2013 ,Hotel Hilton,
Mumbai Intercontinental, Airport,Mumbai,India
INCRED BLE
BILLION DREAMS
PUSHING INDIA’’’SGROWTHAGENDA
Friday, 27th December, 2013, Hotel Hilton, Mumbai International Airport, India
Pharma
Leaders
2013
POWER
BRAND
brating
llence in
thcare
vations
1999
Cele
Exce
Heal
Inno
Since
2. The
game
changer
Satya Brahma
Chairman & Editor -in-Chief-Pharmaleaders
Dear
Colleague...
6th
Annual
Pharmaceutical
Leadership Summit
2013TM
India's pharma market has evolved and shifted gears to set foot on an accelerated growth path. In conclusion, as emerging
markets become increasingly important and India's role among these becomes progressively significant, both domestic and
pharma MNCs will need to adapt their business models, organisations and processes and create customised strategies.
Overall, active participation from domestic and international pharma companies, increased investments and strategic initiatives
will likely underpin future growth and enable the Indian pharma market to break into the global top tier in the present decade.
ICRAexpects 10-12% growth for pharma industry in 2013-14 ICRAhas come out with industry update release on pharma sector.
The research firm, expects the industry to revert to a growth of 10-12% in 2013-14. The impact of new DPCO though expected to
be limited, could also get offset by volume expansion and efforts of industry participants to take price hike in rest of the
portfolio.Growth opportunities intact but managing industry challenges remains key for Indian Pharmaceutical Industry: ICRA
Despite the high-base of the previous year, ICRA believes that the Indian Pharmaceutical industry would continue to experience
strong growth in the near- term however there would some moderation in the growth trajectory. Principally, the generic
opportunities in US will continue to drive revenue growth for Indian pharma companies. This would be an outcome of a) the
sizeable generic opportunity (drugs with brand value of USD 80 billion are expected to face generic competition) over the next 4-5
years, b) strong product pipeline of pending ANDAs with high increasing proportion of complex generics and c) market share
improvement given the relatively small base (share of leading Indian companies is less than 10 percent in the U.S. generics
space). In addition, acquisitions by Indian companies to add technical capabilities and focus on strengthening branded business
(albeit on a small scale) are also likely to drive growth going forward as companies feel the need to diversify.
While growth momentum in the domestic formulation industry slowed down in 2012-13 owing to a confluence of reasons
(discussed above), ICRAbelieves that the industry would revert to its long-term growth trajectory in the medium-term as structural
growth drivers continue to remain impervious. The growth momentum has picked-up over the past few months and with pricing
policy related matters behind us, ICRA expects the industry to revert to a growth of 10- 12 percent in 2013-14. The impact of new
DPCO though expected to be limited, could also get offset by volume expansion and efforts of industry participants to take price
hike in rest of the portfolio. In Europe, the performance of Indian companies improved in 2012-13 in comparison to the prior year
led by primarily new product launches which helped to offset the impact of pricing pressure.
However, given the pace of healthcare reforms and the way competitive landscape is changing in Europe, ICRAbelieves that the
performance of generic companies would remain contingent on new product introductions. As many of the European markets are
gradually shifting character from being 'branded generic' to 'un-branded generic' and from being 'physician-influenced' to 'payor-influenced,
a relook at business plans also appears to be a common theme across companies. Generics companies are
increasingly focusing on expanding presence in relatively underpenetrated markets (i.e. France, Spain & Italy), branded generic
markets of East Europe and niche areas like complex generics, OTCs etc. In general, Indian pharma companies generate a
relatively lower share of revenues from Europe with profitability also subdued compared to other markets. In addition US
generics, emerging markets present one of the most promising growth opportunities for Indian pharmaceutical companies. As
growth prospects normalize in developed markets, companies are increasingly focusing on emerging markets through portfolio
expansion, alliances or JVs and acquisitions, says ICRA. According to ICRA, given the distinct nature of some of the markets
being tapped, managing regulatory hurdles (i.e. delays in receiving approvals in Brazil, healthcare reforms in Russia) and
execution however remains the key. Indian companies though have an inherent advantage given their experience with 'branded
generics' in India. Amongst new frontiers, evolving generic market in Japan (world's second largest pharmaceutical market with
only 23 percent generic penetration) and biosimilars provide alternative growth prospects for Indian companies.
I take this opportunity to invite you to be the part of this historic 6th Edition of Pharmaceutical Leadership Summit & Business
Leadership Awards 2013. I hope your presence at the summit will be an enlightened one.
3. THEME
INCRED BLE
Incredible Pharmaleaders 2013. – " Pushing India's
Growth Agenda-" is the theme of the historic edition
of Pharmaleaders's 6th Leadership Summi t &
Pharmaleaders Business Leadership Awards 2013 to
be staged in Mumbai on 27th Year, the much anticipated &
awaited prestigious title is current state of affairs & the BILLION DREAMS
attempting to revisit the
pressure of building brands
& mo s t imp o r t a n t l y, maintaining the sustainable
growth record in an era PUSHING INDIA’’’SGROWTHAGENDA
where Government's policy
making machine making a Friday, 27th December, 2013, Hotel Hilton, Mumbai International Airport, India
difficult task to the thinking
process & the strategies to retain market dominance. As
Pharmaleader s mar ch ahead to host the event, both
domestic & international markets have been witnessing a change of approach. The Price war, US FDA
Vigilance, FDI & Generics are the key
drivers that will determine the winning combinations.December 2013 in the commercial capital of India,
Mumbai. Entering in its 6thIndian markets are far more mature and have given their thumbs down to the
controversial Food Security Bill. But the UPA government will do all it takes to indulge in such populist
measures even going to the extent of driving the country down the fiscal drain. Fiscal deprivation just adds
on to the long list of pitfalls of the UPA government including corruption, apathy, indecision and pseudo
secularism. Its time for the people of India to fight back. Otherwise its the middle class and the hapless poor
who will pay the price for supporting such a corrupt and inept regime. Pharmaleaders feel the heat when
finding the right perspectives as the overwhelming numbers suggest that the Pricing Policy of the
Government have taken a toll signaling the death of investments in R & D in the absence of a strong
patent regime.
However, the new Drug Prices Control Order (DPCO) 2013 seems to be forcing doctors and patients to
turn to substitutes, courtesy a silent protest by chemists across the state. Chemists are unhappy because
with the DPCO retail chemists are losing 7% commission while wholesalers, about 3% on each drug sold.
Chemists claimed that only 40% of pharma companies in the state have so far agreed to match their
margins. In a landmark decision, the DPCO has lowered prices of 348 essential drugs to bring them within
the reach of every patient.However, it seems a tough time is looming for patients; examine the many
challenges facing the industry and the policy options open to the Indian government to avert an impending
crisis in its capacity to continue the production of cheap generics.
The government of India implemented a series of policy measures in the 1970s to achieve self-sufficiency in
pharmaceutical production. The first step was to revamp the colonial patent legislation and abandon product
patent protection for medicines. Hence, the Patents Act 1970 allowed only process patent protection for
pharmaceutical inventions. As a result, Indian companies could produce new medicines which had been
introduced in the international market but were not available to needy patients in India. This made possible
the production and sale of new medicines at affordable prices.Secondly, the government introduced control
measures on foreign ownership under which foreign companies were not allowed to hold more than 50% of
equity.Thirdly, the government introduced direct price control on all formulations of about 347 bulk
drugs.Fourthly, pharmaceutical multinational corporations (MNCs) were forced to start production of both
formulation and bulk drugs in India.Fifthly, public sector production of bulk drugs encouraged the small and
medium enterprise (SME) sector to start formulation.Within a span of some 20 years, these policy initiatives
cumulatively made India not only self- sufficient but also a net exporter of generic medicines.
www.pharmaleaders2013.com
4. Glimpses of the Magic Moments
POWER Annual
www.pharmaleaders2013.com
INCRED BLE
BILLION DREAMS
PUSHING INDIA’’’S GROWTHAGENDA
Friday, 27th December, 2013, Hotel Hilton, Mumbai International Airport, India
6th
Pharmaceutical
Leadership Summit
2013TM
Pharma
Leaders
2013
BRAND
www.pharmaleaders2013.com
5. Glimpses of the Magic Moments
Pharma
Leaders
2013
POWER
BRAND
www.pharmaleaders2013.com
INCRED BLE
BILLION DREAMS
PUSHING INDIA’’’S GROWTHAGENDA
Friday, 27th December, 2013, Hotel Hilton, Mumbai International Airport, India
www.pharmaleaders2013.com
6. AGENDA 6th
Friday, December 27, 2013
2:00PM - 3:00PM Registration, Reception & Networking High Tea
PROGRAM AGENDA :
6th Annual Pharmaceutical Leadership
Annual
Summit & Pharmaleaders Business Leadership Awards 2013
Opening Address & Summit Moderation
Market Leader ( Life Sciences).Future Steps
( A Korn/Ferry Company)
3:00PM - 3:10PM Mr. S. Krishnakumar (KK),
Theme & Welcome Address
Mr. Satya Brahma
Chairman & Editor-In-Chief –
Pharmaleaders Group
Inaugural Address :
The Rise of India as a Healthcare
powerhouse in the world
Mr. Daara Patel
Secretary General, IDMA
(Indian Drug Manufacturers Association)
Keynote Address
Decoding the success mantra of Indian Pharma
Industry in an era of Govt regulations.
Promoter Director,Salus Lifecare Pvt Ltd
Mr. Kewal Kanda,
Keynote Address
Dr Mukesh Batra,
Founder Chairman, Dr Batra's Positive Health Clinic
Challenges of Globalizing Homeopathic Medicines :
A Dr Batra's Case Study
www.pharmaleaders2013.com
3:10PM - 3:20PM
3:20PM - 3:40PM
3:40PM - 4:00PM
4:00PM - 4:25PM
Pharmaceutical
Leadership Summit
2013TM
7. Government's Perspective
Regulatory Challenges of Indian Plants.
FDA Initiative to curb counterfeit drugs.
Commissioner FDA,
Mr.Mahesh Zagade,
Maharashtra, Government of Maharashtra
The Evolving Profile of the Indian Medical Practioners:
Doctors Expectations from the Pharmaceutical Companies
– Beyond Gifts & Vacation Sponsorships
Dr Shasank. R. Joshi
Consulting Endocrinologist
Panel Discussion: Ethics in Medical Pofession
Dr. Chytra V Anand
Founder&CEO &
Chief Cosmetic Dermatologist
KOSMODERMA
Chairperson
Dr. Siddharth N. Shah
Consulting Physician & Diabetologist
Esteemed Panel Members
Dr.Jothydev Kesavadev
Founder Chairman,
Jothydev's Diabetes
Research Centre
Dr. Rashmi Shetty
Non-Surgical Aesthetic
Medicine Expert
Dr. Kaushal Pandey
Cardiac Surgeon
Dr Shashank R Joshi
Physician Endocrinologist &
Dialectologist
Dr. Sudhir Vaishnav
Interventional Cardiologist
Dr Deepak K Jhumani
Consultant in Sexual
Health and Counsellor
Dr. Harish S. Bhende
Orthopaedic Surgeon,
Dr Laud Clinic.
www.pharmaleaders2013.com
4:25PM - 4:40PM
4:40PM - 5:00PM
5:00PM - 5:30PM
Dr. Deepak Chaturvedi
Physician Endocrinologist & Dialectologist
8. Keynote Address
Dr. Hasit Joshipura
Managing Director, GlaxoSmithKline
Pharmaceuticals Ltd
5:30PM - 5:45PM
Has the Pharmaceutical Companies failed to
impress the doctors on medical education by
adopting unethical means?
Mr. Deepak Naik,
Managing Director, Health 'N' U Therapeutics Pvt. Ltd
5:45PM - 6:00PM
6:00PM - 6:25PM Refreshment Break & Networking
FDI in Pharma. FDI policy of the
Govt to protect domestic generic (off-patent) firms.
Dr.GSK Velu
Founder Chairman, Trivitron Group of Companies
6:35PM - 7:00PM Panel Discussion : The Changing Face of Pharmaleaders
Making of India's Leadership in Medical
Innovation : The Real Time Experience
Dr Naresh Trehan
Cardiovascular and Cardiothoracic Surgeon & CMDS,Medanta
6:25PM - 6:35PM
7:00PM - 7:30PM
The Changing Face of Indian Skin care Innovations
Dr. Shuba Dharmana
Cosmetic Dermatologist CEO & Founder,
Le'jeune Medspa
7:30PM - 7:45PM
Cost effective Healthcare through citizens
community participation
Prof. Dr. Nandkishore
Shamrao Laud
Founder, Dr Laud Clinic
7:45PM - 8:00PM
08.00 pm onwards 6th Annual Pharmaceutical Leadership Summit &
Business Leadership Award 2013 followed by Cocktail & Gala Dinner.
9. 6th
Annual
Pharmaceutical
Leadership Summit
2013TM
REGISTER TODAY
Ticket to this event include all panels, forums, networking,
high tea, dinner, cocktail, award presentation ceremony &
of course cultural extravaganza.
For Group Bookings or
Enquiry, Please contact
Our Event Team At : registrations@pharmaleaders2013.com
INCREDIBLE PHARMALEADERS 2013
BILLION DREAMS – PUSHING INDIA'S GROWTH AGENDA
Friday, 27st December 2013, Hotel Hilton, Mumbai Intercontinental, Airport, Mumbai, India
6th ANNUAL PHARMACEUTICAL LEADERSHIP
SUMMIT & BUSINESS LEADERSHIP AWARDS 2013
REGISTRATION APPLICATION
Registration Informations:
Per Delegate Fees: INR RS 10000 + 12.36 SERVICE TAX
We are pleased to nominate the following participant(s) for the Summit:
Sr : Name : Designation: Email id :
1.______________________________ _______________________ _______________
2.______________________________ _______________________ _______________
3.______________________________ _______________________ _______________
The DD / Cheque No. ________________ for Rs. ________________ towards the delegate fee drawn in favour of
“Dreamz Activations”, payable at Mumbai is enclosed.
Name:________________________________________________Designation :____________
Company:_____________________________________
Address:_______________________________________________________________________________
Telephone:__________________________Fax:_________________________Mobile:_________________
Email:_________________________________________Website:_________________________________
ØPre-Registration and Pre-Payment is a must
Summit Secretariat & Registration Desk.
Dreamz Activations Unit No. 53, 2nd Floor, Aditya Industrial, Estate, CTS No. 1068 - C, Plot No.444 ( P ), Devrukhkar
Wadi, Chincholi Bunder Road, Malad ( W ), Mumbai - 400 064. Phone: + 91 22 4248 1234 / 4248 1235. Email :
pharmasummit2013@webevents.co.in / anish@dreamzactivations.com
Terms & Conditions
ØA 10% discount for 3 or more delegates
Delegate fee non-refundable but change in nomination accepted
Ø
www.pharmaleaders2013.com
10. Individual Non-Voting Award Categories
Business Leader of the Decade India's Most Admired Homeopathic Brand 2013
Incredible Medical Expert of the Decade. (Individual Awards by Jury)
www.pharmaleaders2013.com
Dr Naresh Trehan
Founder Chairman,
Medanta
Prof. Dr. Nandkishore Shamrao Laud
Founder, Dr Laud Clinic
Global Indian of the Year 2013
Mr. Satish Ramanlal Mehta
CEO & MD,
Emcure Pharmaceuticals Limited
Padma Shri Dr. Viswanathan Mohan
Founder & CEO
Dr. Mohan's Diabetes Specialties Centre.
Dr Shasank R Joshi
Consulting Endocrinologist &
Founder, Joshi Clinic
Dr.Jothydev Kesavadev
Founder Chairman,
Jothydev's Diabetes Research Centre
Dr. Kaushal Pandey
Cardiac Surgeon, Jaslok Hospital
Dr. K. Ravindranath
CMD, Global Hospitals Group HelthCare Visionary of the Decade
11. Individual Non-Voting Award Categories
Mr. D.C. Jain
Chairman, Akums Drugs &
Pharmaceuticals Ltd.
www.pharmaleaders2013.com
Lifetime Achievement Award 2013
Pioneering Innovation in Stem Cell Banking Award 2013
Emerging Hospital Chain of the Year 2013
Entrepreneur of the year 2013
Dr G.S.K. Velu
CEO & Managing Director
Trivitron Healthcare
Rising Brand of the Year 2013 Transformational Leader of the Decade
Business Leader of the year
(Healthcare & IT) 2013
Non-Surgical Aesthetic Medicine Expert 2013
Dr. Rashmi Shetty,
CEO & Founder,Ra Skin & Aesthetcs
Mr. Upinder Zutshi
CEO & MD, Infinite Computers (I) Ltd.
Dr Mukesh Batra
Founder Chairman,
Dr Batra's Positive Health Clinic
12. INCRED BLE
BILLION DREAMS
PUSHING INDIA’’’SGROWTHAGENDA
Friday, 27th December, 2013, Hotel Hilton, Mumbai International Airport, India
6th
Annual
Pharmaceutical
Leadership Summit
2013TM
Pharma
Leaders
2013
POWER
BRAND
The Emerging Leader
in SKINCARE innovation